Binx Health

Binx Health is committed to broadening convenient and equitable access to healthcare. The company's point-of-care diagnostic solutions empower its partners to overcome traditional barriers to care, extend their outreach, and deliver exceptional patient experiences. The binx io point-of-care molecular platform marks a significant milestone as the first FDA-cleared, CLIA-waived system for detecting chlamydia and gonorrhea in both males (urine) and females (vaginal swabs). It delivers results comparable to those of central lab performance, typically within about thirty minutes.

Binx Health headquartered in United States, North America, operates in the Mobile, Health Care, Medical Device, Health Diagnostics sector. The company focuses on Mobile and has secured $41.3B in funding across 144 round(s). With a team of 11-50 employees, Binx Health is actively contributing to advancements in Mobile. Their latest funding round, Series B - Binx Health, raised $27.1M. Discover more about their projects, partnerships, and impact on our platform.